Functional Status, Disability, and Symptom-Burden Outcomes

Definition and scope

Measurement of what people can do and how they feel using clearly defined domains and validated assessments, distinguished from diagnosis counts, comorbidity, and administrative utilization. The target population, use, and analysis remain protocol decisions; this card explains the choices and their consequences rather than approving a study.

Operational specification

Name the functional or symptom construct, reporter and instrument, scale direction and range, recall period, assistance/device conventions, time origin, measurement schedule, and change or responder definition. Separate basic activities of daily living, instrumental activities, mobility, pain, fatigue, cognition, and caregiver-observed function rather than treating them as interchangeable scores.

Analysis and diagnostics

Use the instrument-specific scoring and missing-item rules; report distribution, floor/ceiling effects, within-person change and between-group contrasts as appropriate. Establish whether changes exceed measurement error and are meaningful in the target context. Validate administrative or NLP proxies against the intended domain rather than assuming diagnoses imply a particular level of function.

When NOT to use and common errors

Do not interpret comorbidity or frailty indices as equivalent to directly measured functional independence. Do not add different domain scores without a valid scoring model, infer a symptom is absent because it was not documented, or substitute caregiver inference for a patient's internal experience without naming the different reporter.

Worked example and implementation boundary

A synthetic cohort has 30 people meeting a prespecified instrument-based functional criterion among 50 people with observed assessment; ten additional eligible people lack assessment. Calculate the observed-assessment proportion and retain the missing group separately. The observed-assessment proportion is 0.60. It is not the full eligible-cohort proportion unless missingness is addressed. The code performs that explicitly stated calculation with synthetic inputs. It is not a complete fitted analysis and does not demonstrate the identification assumptions, estimate sampling uncertainty, or certify application in another population.

Data-source and reporting requirements

Preserve the provenance, dates, units, and observation rule for each input. Claims capture services and transactions under observable benefits; absence of a record is not proof that an event or resource use did not occur. EHR and registry measurements depend on the collection process and may miss care outside the system. Linked sources add reconciliation and selection questions. Primary collection can improve a missing domain but still requires valid measurement and follow-up. Report which of these limitations affects the stated use, which evidence supports the chosen inputs, and what remains uncertain.

Worked example

Scenario

A synthetic cohort has 30 people meeting a prespecified instrument-based functional criterion among 50 people with observed assessment; ten additional eligible people lack assessment. Calculate the observed-assessment proportion and retain the missing group separately.

Dataset

Synthetic inputs with units defined in the scenario; no patient data.

Steps

Result

The observed-assessment proportion is 0.60. It is not the full eligible-cohort proportion unless missingness is addressed.

Trade-offs

Code example

meeting_criterion = 30
assessed = 50
result = meeting_criterion/assessed
assert abs(result - 0.6) < 1e-9
print(result)

meeting_criterion <- 30
assessed <- 50
result <- meeting_criterion/assessed
stopifnot(abs(result - 0.6) < 1e-9)
print(result)

data worked_example;
  meeting_criterion = 30;
  assessed = 50;
  result = meeting_criterion/assessed;
  put result=;
run;

Citations

1. [1]U.S. Food and Drug Administration. Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments. Final guidance. October 2025.
2. [2]Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality of Life Research. 2010;19(4):539-549.